Jathin Bandari - 10 Jan 2022 Form 3 Insider Report for Protara Therapeutics, Inc. (TARA)

Role: Chief Medical Officer
Signature: Mary Grendell, Attorney-in-Fact
Issuer symbol: TARA
Transactions as of: 10 Jan 2022
Net transactions value: $0
Form type: 3
Filing time: 12 Jan 2022, 16:14:02 UTC
Next filing: 05 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TARA	Common Stock						7,500	10 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TARA	Stock Option (right to buy)							10 Jan 2022	Common Stock	14,500	$28.20	Direct	F2
holding	TARA	Stock Option (right to buy)							10 Jan 2022	Common Stock	2,500	$20.51	Direct	F3
holding	TARA	Stock Option (right to buy)							10 Jan 2022	Common Stock	13,877	$19.82	Direct	F4
holding	TARA	Stock Option (right to buy)							10 Jan 2022	Common Stock	11,123	$19.82	Direct	F4
holding	TARA	Stock Option (right to buy)							10 Jan 2022	Common Stock	523	$6.95	Direct	F5
holding	TARA	Stock Option (right to buy)							10 Jan 2022	Common Stock	1,977	$6.95	Direct	F5
holding	TARA	Stock Option (right to buy)							10 Jan 2022	Common Stock	1,355	$7.02	Direct	F6
holding	TARA	Stock Option (right to buy)							10 Jan 2022	Common Stock	5,145	$7.02	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares reported are issued pursuant to a restricted stock unit award (RSU), of which represents a contingent right to receive one share of Issuer's common stock. The RSU vest in equal one-fourth installments on the first, second, third and fourth anniversaries of July 1, 2020.
F2	25% of the shares vest on the one year anniversary of July 1, 2020 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
F3	25% of the shares vest on the one year anniversary of September 1, 2020 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
F4	25% of the shares vest on the one year anniversary of January 19, 2021 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
F5	25% of the shares vest on the one year anniversary of October 1, 2021 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
F6	25% of the shares vest on the one year anniversary of November 1, 2021 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.